FDA Clears Updated bioMérieux GI Panels With Redesigned Norovirus Assay
The molecular panels feature changes to norovirus and Campylobacter detection intended to improve specificity, with results available in about one hour.
The molecular panels feature changes to norovirus and Campylobacter detection intended to improve specificity, with results available in about one hour.
The Liaison Plex Gastrointestinal Flex Assay detects 24 targets and offers broad parasite coverage with pay-per-target flexibility.
ARUP Laboratories is expanding its AI-augmented screening tool for detecting gastrointestinal parasites to include wet-mount slides.
Researchers developed a PCR-based test that helps gastroenterologists assess the risk of Barrett’s esophagus progressing to cancer.
Read MoreThe AFS requested health insurance providers include the EsoGuard Esophageal test as a covered service to detect esophageal precancer.
Read MoreA partnership aims to offer advanced gut health testing to consumers through retail pharmacies, making these diagnostics more accessible.
Read MoreResearchers have developed a portable, rapid water testing technology to detect Shiga toxigenic Escherichia coli (STEC) bacteria.
Read MoreNew C. diff testing guidelines lead to a significant reduction in inappropriate testing by 20%, which helped decrease overtreatment.
Read MoreLucid Diagnostics celebrates testing the 4,000th firefighter for esophageal precancer using the EsoGuard Esophageal DNA test.
Read MoreThe FDA approved Genetic Signatures’ EasyScreen Gastrointestinal Parasite Detection Kit and GS1 automated workflow for sale in the U.S.
Read MoreAn oral rinse could offer early detection of gastric cancer, the fourth-leading cause of cancer deaths worldwide, according to a new study.
Read MoreBruker enhanced diagnostic solutions in microbial identification, antimicrobial susceptibility testing, early sepsis diagnostics, and more.
Read MoreThe Oncoguard Esophagus test showed high sensitivity and specificity for the detection of esophageal adenocarcinoma and its precursors.
Read MoreLucid Diagnostics announced that a prospective VA screening study demonstrated strong performance of its EsoGuard Esophageal DNA test.
Read MoreBiomerica received FDA 510(k) clearance for a new test designed to detect the presence of the H. pylori bacteria.
Read MoreResearchers have shown that changes can be detected in blood tests up to eight years before a diagnosis of Crohn’s disease.
Read MoreLaboratory services company PathAI Diagnostics unveiled an AI-assisted LDT for the histologic scoring and staging of MASLD and MASH.Â
Read MoreCOVID-19 has reshaped the global landscape of gastrointestinal infections, notably surging norovirus cases. Coupled with an increasing immunity gap due to reduced vaccinations, healthcare systems are on alert. Seegene offers solutions for these unprecedented challenges.
Read More